
CPHI South East Asia 2026
07/2026 – 07/2026
ICURE Pharmaceutical is a biopharmaceutical company positioned to lead advances in transdermal drug delivery technology, applying its advanced technology to pharmaceutical and dermo-cosmetic patches under a core business built on skin-based cure and care solutions. The company actively produces NSAID patches in Asian countries, along with systemic patches such as nicotine and rivastigmine, and is developing innovative products including donepezil patches at its R&D center.

No comments available.
Leave your rating & comment